Milling Simon, Ijaz Umer Zeeshan, Venieri Danae, Christidis George E, Rattray Nicholas J W, Gounaki Iosifina, Andrusaite Anna, Hareendran Aravind, Knapp Charles W, Jones Alexander X, Photos-Jones Effie
Centre for Immunobiology, School of Infection and Immunity, University of Glasgow, Glasgow, United Kingdom.
Water and Environment Group, James Watt School of Engineering, University of Glasgow, Glasgow, United Kingdom.
PLoS One. 2024 Dec 17;19(12):e0313090. doi: 10.1371/journal.pone.0313090. eCollection 2024.
The experiments presented here are based on the reconfiguration of an ancient medicine, Lemnian Earth (LE) (terra sigillata, stamped earth, sphragis), an acclaimed therapeutic clay with a 2500-year history of use. Based on our hypothesis that LE was not a natural material but an artificially modified one involving a clay-fungus interaction, we present results from experiments involving the co-culture of a common fungus, Penicillium purpurogenum (Pp), with two separate clay slurries, smectite and kaolin, which are the principal constituents of LE. Our results show: (a) the leachate of the Pp+smectite co-culture is antibacterial in vitro, inhibiting the growth of both Gram-positive and Gram-negative bacteria; (b) in vivo, supplementation of regular mouse diet with leachates of Pp+smectite increases intestinal microbial diversity; (c) Pp+kaolin does not produce similar results; (d) untargeted metabolomics and analysis of bacterial functional pathways indicates that the Pp+smectite-induced microbiome amplifies production of short-chain fatty acids (SCFAs) and amino acid biosynthesis, known to modulate intestinal and systemic inflammation. Our results suggest that the combination of increased microbial diversity and SCFA production indicates beneficial effects on the host microbiome, thus lending support to the argument that the therapeutic properties of LE may have been based on the potential for modulating the gut microbiome. Our experiments involving reconfigured LE open the door to future research into small molecule-based sources for promoting gut health.
本文所呈现的实验基于一种古老药物——累范土(LE)(印花陶土、印章土、封印土)的重新配置,这是一种有着2500年使用历史的著名治疗用黏土。基于我们的假设,即LE并非天然物质,而是一种涉及黏土 - 真菌相互作用的人工改性物质,我们展示了将一种常见真菌——产紫青霉(Pp)与两种不同的黏土悬浮液(蒙脱石和高岭土,它们是LE的主要成分)进行共培养的实验结果。我们的结果表明:(a)Pp + 蒙脱石共培养的渗滤液在体外具有抗菌作用,可抑制革兰氏阳性菌和革兰氏阴性菌的生长;(b)在体内,用Pp + 蒙脱石的渗滤液补充常规小鼠饮食可增加肠道微生物多样性;(c)Pp + 高岭土未产生类似结果;(d)非靶向代谢组学和细菌功能途径分析表明,Pp + 蒙脱石诱导的微生物群增加了短链脂肪酸(SCFA)的产生和氨基酸生物合成,已知这些可调节肠道和全身炎症。我们的结果表明,微生物多样性增加和SCFA产生的结合表明对宿主微生物群有有益影响,从而支持了LE的治疗特性可能基于调节肠道微生物群的潜力这一观点。我们涉及重新配置LE的实验为未来基于小分子促进肠道健康的研究打开了大门。